Figure 5.
EFS and OS for HTS MRD positive at any level vs negative for the high-risk group. Kaplan-Meier estimates of EFS (A) and OS (B) for patients in the high-risk group who were positive for MRD by HTS at any level vs negative demonstrated better EFS and OS for the HTS-negative cohort, although the P values did not demonstrate statistical significance.